Related Experiment Video
Updated: Nov 24, 2025

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
ARRB2 promotes colorectal cancer growth through triggering WTAP
Hongguang Liang1,2, Zelong Lin1, Youqiong Ye3
1Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510315, China.
β-arrestin2 (ARRB2) is upregulated in colorectal cancer (CRC), promoting tumor growth and migration. Suppressing ARRB2 inhibits CRC progression by regulating Wilms tumor 1 associated protein (WTAP) expression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
- The precise mechanisms driving CRC progression, particularly the role of β-arrestin2 (ARRB2), remain incompletely understood.
- Investigating novel molecular targets is crucial for developing effective CRC therapies.
Purpose of the Study:
- To elucidate the role and mechanism of β-arrestin2 (ARRB2) in colorectal cancer progression.
- To determine the correlation between ARRB2 expression levels and patient survival outcomes.
- To identify downstream pathways regulated by ARRB2 in CRC.
Main Methods:
- Analysis of Cancer Genome Atlas (TCGA) data for ARRB2 expression.
- Western blot and immunohistochemistry to validate ARRB2 levels in CRC tissues.
- Kaplan-Meier analysis to assess the correlation between ARRB2 expression and overall survival.
- In vitro and in vivo models to evaluate the functional impact of ARRB2 suppression on CRC progression, including azoxymethane/dextran sodium sulfate-induced CRC models.
- Gene knockdown experiments to investigate ARRB2's effect on cancer-related pathways, specifically those involving Wilms tumor 1 associated protein (WTAP).
Main Results:
- ARRB2 expression is significantly upregulated in colorectal cancer tissues compared to normal tissues.
- Higher ARRB2 levels correlate with poorer overall patient survival.
- Increased ARRB2 expression enhances CRC cell proliferation, migration, and inhibits apoptosis.
- Suppression of ARRB2 effectively attenuates CRC progression in experimental models.
- Knockdown of ARRB2 leads to decreased expression of cancer pathways mediated by WTAP, inhibiting cell proliferation and migration.
Conclusions:
- β-arrestin2 (ARRB2) plays a significant role in promoting colorectal cancer growth and metastasis.
- ARRB2 promotes CRC progression by regulating Wilms tumor 1 associated protein (WTAP) expression.
- Targeting ARRB2 may represent a potential therapeutic strategy for colorectal cancer.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Canonical Wnt Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Non-Canonical Wnt Signaling Pathways